Stockreport

Evolus Reports Third Quarter 2024 Results

Evolus, Inc.  (EOLS) 
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
PDF Total Net Revenue of $61.1 Million for Q3 2024, Up 22% from Q3 2023; Year-To-Date Growth of 33%Received Approval for Estyme® Injectable Hyaluronic Acid (HA) Gels in the [Read more]